J3385 Velaglucerase alfa
J-Codes
Also known as: velaglucerase alfa, VPRIV, enzyme replacement therapy
Velaglucerase alfa injection is a recombinant enzyme replacement therapy used for Gaucher disease Type 1 treatment.
Clinical Context
Used in Gaucher disease Type 1 for enzyme replacement therapy. Recombinant glucocerebrosidase that reduces hepatosplenomegaly and hematologic abnormalities. Administered intravenously every 2 weeks.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.